4/12
08:02 am
lucd
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.
Medium
Report
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.
4/12
04:35 am
lucd
Rating for LUCD
Medium
Report
Rating for LUCD
4/12
04:35 am
lucd
Rating for LUCD
Medium
Report
Rating for LUCD
3/27
10:00 am
lucd
Rating for LUCD
Low
Report
Rating for LUCD
3/27
08:09 am
lucd
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.
Low
Report
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.
3/27
05:18 am
lucd
Rating for LUCD
Medium
Report
Rating for LUCD
3/27
05:18 am
lucd
Rating for LUCD
Medium
Report
Rating for LUCD
2/27
08:02 am
lucd
Lucid Diagnostics initiated with bullish view at Maxim
Low
Report
Lucid Diagnostics initiated with bullish view at Maxim